A
Alamar Biosciences, Inc.
ALMR · NASDAQ · Healthcare · 2.3B
Price · close
$34.24
-1.15% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-59.3×
Free cash flow yieldFCF yield
-4.1%
Return on equityROE
18.8%
Operating margin
-42.2%
Net debt / EBITDAbalance-sheet strength
-0.5×
Interest coverage
-78.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.